AEVI GENOMIC MEDICINE INC's ticker is GNMX and the CUSIP is 00835P105. A total of 49 filers reported holding AEVI GENOMIC MEDICINE INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $24,000 | +100.0% | 161,612 | +103.3% | 0.00% | +100.0% |
| Q3 2019 | $12,000 | +50.0% | 79,509 | +68.7% | 0.00% | – |
| Q2 2019 | $8,000 | -85.5% | 47,137 | -83.1% | 0.00% | -100.0% |
| Q1 2019 | $55,000 | +120.0% | 278,958 | +675.7% | 0.00% | +200.0% |
| Q4 2018 | $25,000 | +56.2% | 35,964 | +174.2% | 0.00% | 0.0% |
| Q3 2018 | $16,000 | -64.4% | 13,115 | -63.4% | 0.00% | -50.0% |
| Q3 2017 | $45,000 | – | 35,862 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Birchview Capital, LP | 128,000 | $154,000 | 0.09% |
| Baker Brothers Advisors | 4,055,142 | $4,866,000 | 0.04% |
| Verity Asset Management, Inc. | 14,500 | $28,000 | 0.02% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,500,000 | $6,600,000 | 0.02% |
| HYMAN CHARLES D | 15,143 | $18,000 | 0.00% |
| Cable Hill Partners, LLC | 4,000 | $5,000 | 0.00% |
| Wealthcare Advisory Partners LLC | 5,000 | $6,000 | 0.00% |
| A.R.T. Advisors, LLC | 41,879 | $50,000 | 0.00% |
| Legacy Advisors, LLC | 2,450 | $2,000 | 0.00% |
| OneDigital Investment Advisors LLC | 7,800 | $9,000 | 0.00% |